4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-008246
Chief Scientific Officer sold 7,790 shares at an average $59.58 ($464,158)
- Chief Scientific Officer acquired 7,790 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-03 | Option exercise | +7,790 | $6.32 | $49,233 | 8,469 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-03 | Sale | −6,930 | $59.49 | $412,266 | 1,539 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-03 | Sale | −860 | $60.34 | $51,892 | 679 | D: show line 3 in the form |
| Open-market sales · 7,790 sh · avg $59.58 · $464,158 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2021-02-03 | Option exercise · Stock Option (Right to Buy) | −7,790 | 186,960 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…